Looi J, Allison S, Woon L, Bastiampillai T
Australas Psychiatry. 2023; 32(1):55-58.
PMID: 37903482
PMC: 10809724.
DOI: 10.1177/10398562231211129.
Huwel L, Van Eessen J, Gunst J, Malbrain M, Bosschem V, Vanacker T
Heliyon. 2023; 9(2):e13471.
PMID: 36816284
PMC: 9929305.
DOI: 10.1016/j.heliyon.2023.e13471.
Ooi K
Asian Bioeth Rev. 2021; 12(4):399-417.
PMID: 33717342
PMC: 7747436.
DOI: 10.1007/s41649-020-00145-z.
Dainty K, Seaton M, Drennan I, Morrison L
Health Serv Res. 2018; 53(5):3455-3470.
PMID: 29542111
PMC: 6153157.
DOI: 10.1111/1475-6773.12855.
Robertson-Preidler J, Biller-Andorno N, Johnson T
BMC Health Serv Res. 2017; 17(1):452.
PMID: 28666438
PMC: 5493089.
DOI: 10.1186/s12913-017-2357-2.
Skin Cancer in U.S. Elderly Adults: Does Life Expectancy Play a Role in Treatment Decisions?.
Linos E, Chren M, Cenzer I, Covinsky K
J Am Geriatr Soc. 2016; 64(8):1610-5.
PMID: 27303932
PMC: 5459407.
DOI: 10.1111/jgs.14202.
Addressing the Concerns Surrounding Continuous Deep Sedation in Singapore and Southeast Asia: A Palliative Care Approach.
Krishna L
J Bioeth Inq. 2015; 12(3):461-75.
PMID: 26173777
DOI: 10.1007/s11673-015-9651-7.
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Bertolotto A, Capobianco M, Amato M, Capello E, Capra R, Centonze D
Neurol Sci. 2013; 35(2):307-16.
PMID: 24374787
DOI: 10.1007/s10072-013-1616-1.
Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer.
Linos E, Parvataneni R, Stuart S, Boscardin W, Landefeld C, Chren M
JAMA Intern Med. 2013; 173(11):1006-12.
PMID: 23699934
PMC: 3726204.
DOI: 10.1001/jamainternmed.2013.639.
Conceptual, methodological, and ethical problems in communicating uncertainty in clinical evidence.
Han P
Med Care Res Rev. 2012; 70(1 Suppl):14S-36S.
PMID: 23132891
PMC: 4238424.
DOI: 10.1177/1077558712459361.
Impedance of novel therapeutic technologies: the case of stem cells.
Zacharias D, Nelson T, Mueller P, Hook C
Clin Transl Sci. 2012; 5(5):422-7.
PMID: 23067356
PMC: 5439797.
DOI: 10.1111/j.1752-8062.2012.00434.x.
Twenty-four-hour intensivist staffing in teaching hospitals: tensions between safety today and safety tomorrow.
Kerlin M, Halpern S
Chest. 2012; 141(5):1315-1320.
PMID: 22553264
PMC: 3342782.
DOI: 10.1378/chest.11-1459.
Moving molecular targeted drug therapy towards personalized medicine: issues related to clinical trial design.
Verweij J, de Jonge M, Eskens F, Sleijfer S
Mol Oncol. 2012; 6(2):196-203.
PMID: 22386481
PMC: 5528372.
DOI: 10.1016/j.molonc.2012.01.009.
Sharing individual research results with biospecimen contributors: counterpoint.
Clayton E
Cancer Epidemiol Biomarkers Prev. 2012; 21(2):260-1.
PMID: 22313940
PMC: 3815582.
DOI: 10.1158/1055-9965.EPI-11-0860.
The role of gene and cell therapy in the era of health care reform.
Ettinger W, Flotte T
Hum Gene Ther. 2011; 22(11):1307-9.
PMID: 22023350
PMC: 6463979.
DOI: 10.1089/hum.2011.2526.
